Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4106336 | 0.93 | MAPT (0.54) | PPARGPPARA | |
| SCHEMBL4104255 | 0.90 | PPARG (0.55) | PPARGPPARA | |
| SCHEMBL4096973 | 0.86 | PPARG (0.59) | PPARGPPARA | |
| SCHEMBL4098230 | 0.85 | MAPT (0.62) | PPARGPPARA | |
| SCHEMBL4096642 | 0.83 | MAPT (0.53) | PPARGPPARA | |
| SCHEMBL4036791 | 0.80 | PPARG (0.67) | PPARGPPARA | |
| SCHEMBL4103337 | 0.80 | PPARG (0.57) | PPARGPPARA | |
| SCHEMBL4092567 | 0.80 | PPARG (0.57) | PPARGPPARA | |
| SCHEMBL4103703 | 0.80 | MAPT (0.60) | PPARGPPARA | |
| SCHEMBL7740069 | 0.80 | PPARG (0.69) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1911738-A1 | PHENOXYALKANOIC ACID COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | PNLIP, GPR119, LIPC | PPARG 23/4885PPARA 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.